“All I want for Christmas is Two”: The Advent of Novel Fixed-Combination Inhalers for COPD and Outlook for 2014

por Beeh, Kai M.
Publicado 2013

The Role of Bronchodilators in Preventing Exacerbations of Chronic Obstructive Pulmonary Disease

por Beeh, Kai M.
Publicado 2016

And Then There Were Three: Time to Move Onward in COPD Drug Development Beyond LAMA/LABA/ICS at Last?

por Beeh, Kai M.
Publicado 2018

Indacaterol: a new once daily long-acting beta(2) adrenoceptor agonist

por Beeh, Kai M, Beier, Jutta
Publicado 2010

Long-acting β-adrenoceptor agonists in the management of COPD: focus on indacaterol

por Beier, Jutta, Beeh, Kai M
Publicado 2011

Once-daily NVA237 improves exercise tolerance from the first dose in patients with COPD: the GLOW3 trial

por Beeh, Kai M, Singh, Dave, Di Scala, Lilla, Drollmann, Anton
Publicado 2012

Tiotropium and Salmeterol in COPD Patients at Risk of Exacerbations: A Post Hoc Analysis from POET-COPD(®)

por Vogelmeier, Claus F., Asijee, Guus M., Kupas, Katrin, Beeh, Kai M.
Publicado 2015

Dose–response of an extrafine dry powder inhaler formulation of glycopyrronium bromide: randomized, double-blind, placebo-controlled, dose-ranging study (GlycoNEXT)

por Beeh, Kai M, Emirova, Aida, Prunier, Hélène, Santoro, Debora, Nandeuil, Marie Anna
Publicado 2018

Characterisation of exacerbation risk and exacerbator phenotypes in the POET-COPD trial

por Beeh, Kai M, Glaab, Thomas, Stowasser, Susanne, Schmidt, Hendrik, Fabbri, Leonardo M, Rabe, Klaus F, Vogelmeier, Claus F
Publicado 2013

The environmental impact of inhaled therapy: making informed treatment choices

por Woodcock, Ashley, Beeh, Kai M., Sagara, Hironori, Aumônier, Simon, Addo-Yobo, Emmanuel, Khan, Javaid, Vestbo, Jørgen, Tope, Helen
Publicado 2022

Aclidinium improves exercise endurance, dyspnea, lung hyperinflation, and physical activity in patients with COPD: a randomized, placebo-controlled, crossover trial

por Beeh, Kai M, Watz, Henrik, Puente-Maestu, Luis, de Teresa, Luis, Jarreta, Diana, Caracta, Cynthia, Gil, Esther Garcia, Magnussen, Helgo
Publicado 2014

Early bronchodilator action of glycopyrronium versus tiotropium in moderate-to-severe COPD patients: a cross-over blinded randomized study (Symptoms and Pulmonary function in the m...

por Marin, Jose M, Beeh, Kai M, Clemens, Andreas, Castellani, Walter, Schaper, Lennart, Saralaya, Dinesh, Gunstone, Anthony, Casamor, Ricard, Kostikas, Konstantinos, Aalamian-Mattheis, Maryam
Publicado 2016

ACTIVATE: the effect of aclidinium/formoterol on hyperinflation, exercise capacity, and physical activity in patients with COPD

por Watz, Henrik, Troosters, Thierry, Beeh, Kai M, Garcia-Aymerich, Judith, Paggiaro, Pierluigi, Molins, Eduard, Notari, Massimo, Zapata, Antonio, Jarreta, Diana, Garcia Gil, Esther
Publicado 2017

Cost-Effectiveness of Single- versus Multiple-Inhaler Triple Therapy in a UK COPD Population: The INTREPID Trial

por Halpin, David M G, Kendall, Robyn, Shukla, Soham, Martin, Alan, Shah, Dhvani, Midwinter, Dawn, Beeh, Kai M, Kocks, Janwillem W H, Jones, Paul W, Compton, Chris, Risebrough, Nancy A, Ismaila, Afisi S
Publicado 2022

Maximizing Adherence and Gaining New Information For Your Chronic Obstructive Pulmonary Disease (MAGNIFY COPD): Study Protocol for the Pragmatic, Cluster Randomized Trial Evaluatin...

por Price, David, Jones, Rupert, Pfister, Pascal, Cao, Hui, Carter, Victoria, Kemppinen, Anu, Holzhauer, Björn, Kaplan, Alan, Clark, Allan, Halpin, David M G, Pinnock, Hilary, Chalmers, James D, van Boven, Job F M, Beeh, Kai M, Kostikas, Konstantinos, Roche, Nicolas, Usmani, Omar, Mastoridis, Paul
Publicado 2021